The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of trifluridine/tipiracil (FTD/TPI) and oxaliplatin as induction chemotherapy (IC) in resectable esophageal and gastroesophageal junction adenocarcinoma (EGAC).
 
Sarbajit Mukherjee
Research Funding - Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst)
 
Hussein Assi
No Relationships to Disclose
 
Christos Fountzilas
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
 
Kristopher Attwood
No Relationships to Disclose
 
Patrick McKay Boland
Honoraria - Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical
Consulting or Advisory Role - Merrimack; Merrimack; Merrimack; Merrimack; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Research Funding - Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Athenex (Inst); Athenex (Inst); Athenex (Inst); Athenex (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Merrimack (Inst); Theradiag (Inst); Theradiag (Inst); Theradiag (Inst); Theradiag (Inst)
 
Renuka V. Iyer
Honoraria - Ipsen; Ipsen; Ipsen; Ipsen
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Lexicon; Lexicon; Lexicon; Lexicon; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis
Research Funding - Cleveland BioLabs (Inst); Cleveland BioLabs (Inst); Cleveland BioLabs (Inst); Cleveland BioLabs (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Daniel V.T. Catenacci
Honoraria - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genmab; Genmab; Genmab; Genmab; Gritstone Bio; Gritstone Bio; Gritstone Bio; Gritstone Bio; Guardant Health; Guardant Health; Guardant Health; Guardant Health; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; NantWorks; NantWorks; NantWorks; NantWorks; OncoPlex Diagnostics; OncoPlex Diagnostics; OncoPlex Diagnostics; OncoPlex Diagnostics; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Genentech; Genentech; Genentech; Genentech; Guardant Health; Guardant Health; Guardant Health; Guardant Health; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Merck; Merck; Merck; Merck
 
Hassan Hatoum
Consulting or Advisory Role - Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine